NIH-funded research R21 grant

How nerve cells in the lungs affect immune responses to severe bacterial infections

Official title: Lung-innervating nociceptor sensory neurons suppresses Ly6chi monocyte responses to promote pneumonic sepsis

Funded at Kansas State University · NIH-11058069 · Data updated 2026-11-12

This study is looking at how certain nerve cells in the lungs help the body fight off tough lung infections caused by a bacteria called Klebsiella pneumoniae, with the goal of finding new ways to help people who are seriously ill from these infections.

More Sepsis research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionKansas State University
NIH-funded
Lab location1 site (Manhattan, United States)
Project startDecember 1, 2024
Project endNovember 30, 2026
Funding year2025
Award (this year)$228,000
NIH project number1R21AI186057-01A1
Project IDNIH-11058069 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are hospitalized patients with pneumonia caused by carbapenem-resistant Klebsiella pneumoniae.

Less likely to help

Patients with pneumonia caused by other types of bacteria or those who do not have severe immune suppression may not benefit from this research.

What this research studies

This research investigates the role of lung-innervating nociceptor sensory neurons in the immune response to carbapenem-resistant Klebsiella pneumoniae, a bacteria that causes severe lung infections and sepsis. The study aims to understand how these neurons and the neuropeptides they release can influence the body's ability to fight off this infection. By using various experimental techniques in mice, including manipulating neuronal functions and observing immune responses, the researchers hope to uncover new therapeutic targets for improving outcomes in patients with pneumonic sepsis.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that enhance the immune response in patients suffering from severe bacterial pneumonia and sepsis.

How similar studies have gone: While the specific approach of targeting nociceptor neurons in this context is novel, similar research has shown promise in understanding immune modulation through neuropeptides.

Where this research is happening

  • Kansas State University
    Manhattan, United States
    Active

Researchers

  • Principal investigator: Baral, Pankaj — Kansas State University
  • Study coordinator: Baral, Pankaj

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.